Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial
Diabetologia · 2023
DOI: 10.1007/s00125-023-06006-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetologia, 2023. Verfasst von Merel M Ruissen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Self-Management, Hypoglycemia. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme.
Themen: Diabetes mellitus, Selbstmanagement bei chronischen Erkrankungen
Abstract (Originalsprache)
Aims/hypothesis There is a lack of e-health systems that integrate the complex variety of aspects relevant for diabetes self-management. We developed and field-tested an e-health system (POWER2DM) that integrates medical, psychological and behavioural aspects and connected wearables to support patients and healthcare professionals in shared decision making and diabetes self-management.
Methods
Participants with type 1 or type 2 diabetes (aged >18 years) from hospital outpatient diabetes clinics in the Netherlands and Spain were randomised using randomisation software to POWER2DM or usual care for 37 weeks. This RCT assessed the change in HbA 1c between the POWER2DM and usual care groups at the end of the study (37 weeks) as a primary outcome measure. Participants and clinicians were not blinded to the intervention. Changes in quality of life (QoL) (WHO-5 Well-Being Index [WHO-5]), diabetes self-management (Diabetes Self-Management Questionnaire – Revised [DSMQ-R]), glycaemic profiles from continuous glucose monitoring devices, awareness of hypoglycaemia (Clarke hypoglycaemia unawareness instrument), incidence of hypoglycaemic episodes and technology acceptance were secondary outcome measures. Additionally, sub-analyses were performed for participants with type 1 and type 2 diabetes separately.
Results
A total of 226 participants participated in the trial (108 with type 1 diabetes; 118 with type 2 diabetes). In the POWER2DM group ( n =111), HbA 1c decreased from 60.6±14.7 mmol/mol (7.7±1.3%) to 56.7±12.1 mmol/mol (7.3±1.1%) (means ± SD, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Biomedical Data Sciences, Medical Decision Making Section, Leiden University Medical Center, Leiden, the Netherlands.
- Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Córdoba, Spain.
- Department of Medical and Surgical Sciences, University of Córdoba, Córdoba, Spain.
- Maimonides Biomedical Research Institute of Córdoba, Córdoba, Spain.
- Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Förderung
- Horizon 2020 Framework Programme
Zitieren
APA
Ruissen, M. M., Torres-Peña, J. D., Uitbeijerse, B. S., Arenas de Larriva, A. P., Huisman, S. D., Namli, T., Salzsieder, E., Vogt, L., Ploessnig, M., van der Putte, B., Merle, A., Serra, G., Rodríguez, G., de Graaf, A. A., de Koning, E. J. P., Delgado-Lista, J., Sont, J. K., & POWER2DM Consortium (2023). Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial. Diabetologia. https://doi.org/10.1007/s00125-023-06006-2
Vancouver
Ruissen MM, Torres-Peña JD, Uitbeijerse BS, Arenas de Larriva AP, Huisman SD, Namli T, et al. Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial. Diabetologia. 2023. doi:10.1007/s00125-023-06006-2
BibTeX
@article{Ruissen2023,
author = {Ruissen, Merel M and Torres-Peña, José D and Uitbeijerse, Bas S and Arenas de Larriva, Antonio P and Huisman, Sasja D and Namli, Tuncay and Salzsieder, Eckhard and Vogt, Lutz and Ploessnig, Manuela and van der Putte, Bob and Merle, Armelle and Serra, Gustavo and Rodríguez, Gustavo and de Graaf, Albert A and de Koning, Eelco J P and Delgado-Lista, Javier and Sont, Jacob K and POWER2DM Consortium, POWER2DM Consortium},
title = {Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial},
journal = {Diabetologia},
year = {2023},
doi = {10.1007/s00125-023-06006-2}
}
EUVIMED